Online dating cancer survivors

(2) Poor prognostic indicators include an incomplete or short-lived response to prior therapy; negative hormone receptor status; involvement of a major organ like the liver or brain; and multiple sites of involvement.Patient FK is a 71-year-old woman who had been in good health when in mid-1984, she first noticed a right breast mass.She had previously been in good health when in the fall of 1986, routine mammography revealed a suspicious mass in the left breast, confirmed by biopsy as ductal carcinoma in situ.

Usually, we discourage patients from beginning our program if they will be continuing chemotherapy, but in this case, I agreed to the combined approach.Although her course was initially complicated because she continued chemotherapy, at her oncologist�s insistence, any drug effect can be discounted since she had developed metastatic disease while completing a two year course of chemotherapy.Also, chemotherapy, no matter the type, does not cure metastatic breast cancer into the bone.For many years, she avoided radiographic testing until May 2001, when a bone scan showed that the previously evident lesions had resolved completely.The official reports �No definite abnormal uptake of radiotracer suggesting skeletal metastasis.� Today, 19 years after her recurrence, and 21 years since her original diagnosis of aggressive disease, she remains in excellent health with no evidence of cancer.

Leave a Reply